Skip to main content

Peer Review reports

From: Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi

Original Submission
6 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Sep 2022 Reviewed Reviewer Report
20 Dec 2022 Reviewed Reviewer Report
20 Jan 2023 Reviewed Reviewer Report
7 Feb 2023 Author responded Author comments - Tom Michael Quinn
Resubmission - Version 3
7 Feb 2023 Submitted Manuscript version 3
10 Feb 2023 Author responded Author comments - Tom Michael Quinn
Resubmission - Version 4
10 Feb 2023 Submitted Manuscript version 4
20 Feb 2023 Author responded Author comments - Tom Michael Quinn
Resubmission - Version 5
20 Feb 2023 Submitted Manuscript version 5
4 Mar 2023 Reviewed Reviewer Report
13 Apr 2023 Author responded Author comments - Tom Michael Quinn
Resubmission - Version 6
13 Apr 2023 Submitted Manuscript version 6
17 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
27 Apr 2023 Editorially accepted
15 May 2023 Article published 10.1186/s12879-023-08286-w

You can find further information about peer review here.

Back to article page